202 related articles for article (PubMed ID: 33594364)
1. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
Cillo AR; Somasundaram A; Shan F; Cardello C; Workman CJ; Kitsios GD; Ruffin A; Kunning S; Lampenfeld C; Onkar S; Grebinoski S; Deshmukh G; Methe B; Liu C; Nambulli S; Andrews L; Duprex WP; Joglekar AV; Benos PV; Ray P; Ray A; McVerry BJ; Zhang Y; Lee JS; Das J; Singh H; Morris A; Bruno TC; Vignali DAA
bioRxiv; 2021 Feb; ():. PubMed ID: 33594364
[TBL] [Abstract][Full Text] [Related]
2. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.
Cillo AR; Somasundaram A; Shan F; Cardello C; Workman CJ; Kitsios GD; Ruffin AT; Kunning S; Lampenfeld C; Onkar S; Grebinoski S; Deshmukh G; Methe B; Liu C; Nambulli S; Andrews LP; Duprex WP; Joglekar AV; Benos PV; Ray P; Ray A; McVerry BJ; Zhang Y; Lee JS; Das J; Singh H; Morris A; Bruno TC; Vignali DAA
Cell Rep Med; 2021 Dec; 2(12):100476. PubMed ID: 34873589
[TBL] [Abstract][Full Text] [Related]
3. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
4. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
5. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific immune dysregulation in severely ill COVID-19 patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Chiang GC; Kassar AG; Patel N; Green CE; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
medRxiv; 2020 Jul; ():. PubMed ID: 32743611
[TBL] [Abstract][Full Text] [Related]
8. Machine learning decision tree algorithm role for predicting mortality in critically ill adult COVID-19 patients admitted to the ICU.
Elhazmi A; Al-Omari A; Sallam H; Mufti HN; Rabie AA; Alshahrani M; Mady A; Alghamdi A; Altalaq A; Azzam MH; Sindi A; Kharaba A; Al-Aseri ZA; Almekhlafi GA; Tashkandi W; Alajmi SA; Faqihi F; Alharthy A; Al-Tawfiq JA; Melibari RG; Al-Hazzani W; Arabi YM
J Infect Public Health; 2022 Jul; 15(7):826-834. PubMed ID: 35759808
[TBL] [Abstract][Full Text] [Related]
9. Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection.
Molinero M; Gómez S; Benítez ID; Vengoechea JJ; González J; Polanco D; Gort-Paniello C; Moncusí-Moix A; García-Hidalgo MC; Perez-Pons M; Belmonte T; Torres G; Caballero J; Barberà C; Ayestarán Rota JI; Socías Crespí L; Ceccato A; Fernández-Barat L; Ferrer R; Garcia-Gasulla D; Lorente-Balanza JÁ; Menéndez R; Motos A; Peñuelas O; Riera J; Torres A; Barbé F; de Gonzalo-Calvo D
Front Immunol; 2022; 13():942443. PubMed ID: 35967328
[TBL] [Abstract][Full Text] [Related]
10. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
11. Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.
Morrell ED; Bhatraju PK; Sathe NA; Lawson J; Mabrey L; Holton SE; Presnell SR; Wiedeman A; Acosta-Vega C; Mitchem MA; Liu T; Chai XY; Sahi S; Brager C; Orlov M; Sakr SS; Sader A; Lum DM; Koetje N; Garay A; Barnes E; Cromer G; Bray MK; Pipavath S; Fink SL; Evans L; Long SA; West TE; Wurfel MM; Mikacenic C
Am J Physiol Lung Cell Mol Physiol; 2022 Jul; 323(1):L14-L26. PubMed ID: 35608267
[TBL] [Abstract][Full Text] [Related]
12. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
13. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
14. Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 disease.
Acosta-Altamirano G; Garduño-Javier E; Hernández-Gómez V; Espinosa JA; Vaca-Paniagua F; Rodríguez-Sosa M; Juárez-Avelar I; Terrazas LI; Bravata-Alcántara JC; Sierra-Martínez M; Olguín JE
Appl Microbiol Biotechnol; 2022 Dec; 106(23):7905-7916. PubMed ID: 36342507
[TBL] [Abstract][Full Text] [Related]
15. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
16. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
17. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.
Penttilä PA; Van Gassen S; Panovska D; Vanderbeke L; Van Herck Y; Quintelier K; Emmaneel A; Filtjens J; Malengier-Devlies B; Ahmadzadeh K; Van Mol P; Borràs DM; Antoranz A; Bosisio FM; Wauters E; Martinod K; Matthys P; Saeys Y; Garg AD; Wauters J; De Smet F;
Cell Mol Life Sci; 2021 Apr; 78(8):3987-4002. PubMed ID: 33715015
[TBL] [Abstract][Full Text] [Related]
18. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
20.
Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
Front Immunol; 2022; 13():897995. PubMed ID: 35860236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
